Quest Diagnostics Incorporated
DGX
$234.40
-$1.64-0.70%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.11% | 3.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.11% | 3.17% | |||
| Cost of Revenue | 3.28% | 3.17% | |||
| Gross Profit | 8.90% | 3.17% | |||
| SG&A Expenses | 5.62% | 2.47% | |||
| Depreciation & Amortization | 2.70% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.82% | 2.90% | |||
| Operating Income | 12.90% | 4.85% | |||
| Income Before Tax | 24.85% | 0.30% | |||
| Income Tax Expenses | 18.92% | -8.64% | |||
| Earnings from Continuing Operations | 26.52% | 3.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -16.67% | -9.09% | |||
| Net Income | 26.98% | 2.86% | |||
| EBIT | 12.90% | 4.85% | |||
| EBITDA | 9.32% | 3.91% | |||
| EPS Basic | 25.95% | 3.38% | |||
| Normalized Basic EPS | 21.21% | 2.27% | |||
| EPS Diluted | 26.79% | 1.84% | |||
| Normalized Diluted EPS | 22.31% | 1.35% | |||
| Average Basic Shares Outstanding | 0.91% | -0.90% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | 0.00% | 7.50% | |||
| Payout Ratio | -0.14% | -0.05% | |||